Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Pediatric Rehabilitation

Standard of Care and Symptom Management

At a Glance

There is no single cure for X-linked intellectual disability-hypotonia-movement disorder because different genes can cause it. Early, individualized therapy and support for movement, communication, swallowing, and nutrition are used to promote comfort, safety, and daily function.

Because X-linked intellectual disability-hypotonia-movement disorder is a “clinical description” covering several different genes, there is no single “cure” or universal treatment protocol. Instead, the standard of care is multidisciplinary management—a team-based approach tailored to your child’s specific gene, symptoms, and daily needs [1].

The primary goal of treatment is not to “fix” the underlying genetic change, but to maximize your child’s comfort, participation in family life, and functional abilities [2].

The Core Therapies: PT, OT, and Speech

Therapy is the “engine” of your child’s care plan. These services should begin as early as possible and be adjusted as your child grows.

  • Physical Therapy (PT): Focuses on gross motor skills. Goals often include improving head control, finding the best sitting or standing alignment, and preventing contractures (permanent tightening of muscles and joints) [3][4].
  • Occupational Therapy (OT): Focuses on fine motor skills and “activities of daily living.” This may involve specialized seating, adaptive spoons for feeding, or splints to keep hands in a functional position [5].
  • Speech and Language Therapy: Beyond learning to speak, these therapists are experts in Augmentative and Alternative Communication (AAC). This can range from “low-tech” picture boards to “high-tech” eye-gaze tablets that allow a child to “speak” with their eyes [6][7]. AAC is recommended early to ensure a child has a way to express their needs and feelings [8].

Managing Movement: Medications and Injections

When movement disorders like dystonia or spasticity interfere with comfort, sleep, or caregiving, your doctor may suggest a trial of medication. Every child responds differently, so these are often started at low doses and monitored closely. Treatment choices depend heavily on whether the child has spasticity, dystonia, or another movement disorder [9].

Treatment Type Common Names Primary Goal Important Safety Considerations
Oral Medications Baclofen, Trihexyphenidyl To reduce overall muscle stiffness or “twisting” [10]. Baclofen can cause sedation and weakness, and must not be stopped abruptly because withdrawal can be dangerous. Trihexyphenidyl can cause anticholinergic effects like dry mouth, constipation, or urinary problems [11].
Focal Injections Botulinum Toxin (Botox) To relax a specific muscle group (e.g., tight hamstrings) [12]. Temporary (lasts 3–4 months); carries dose- and muscle-specific risks and requires specialist oversight for safety [13].
Advanced Options Intrathecal Baclofen A pump that delivers medication directly to the spinal fluid [14]. Reserved for severe cases where oral meds aren’t enough; involves pump, surgical, infection, and withdrawal risks [15].

Nutrition and Swallowing Support

Children with low tone and movement disorders are at high risk for dysphagia (swallowing difficulties). This can lead to aspiration, where food or liquid enters the lungs instead of the stomach [16].

  • Safety Checks: If a child is coughing, choking, or has wet breathing, they need a clinical feeding assessment. Doctors may recommend a Video Fluoroscopic Swallow Study (VFSS) or FEES—because aspiration in these children is often “silent” (they don’t cough) [17][18].
  • Feeding Tubes (G-tubes): If swallowing is unsafe or if a child isn’t gaining enough weight, a G-tube can improve nutrition and reduce the burden and stress of oral feeding [19]. However, a G-tube does not eliminate the aspiration of saliva or reflux. Any “pleasure feeds” by mouth should occur only under an individualized swallow plan.

A Roadmap for Decision-Making

As your child’s symptoms change, use this checklist to guide discussions with your care team about new interventions:

  1. Define the Problem: Is the symptom causing pain, preventing sleep, or making care (like diapering) difficult?
  2. Set a Specific Goal: Instead of “better movement,” aim for “able to sit in a wheelchair for two hours” or “stops waking up from leg spasms.”
  3. Choose a “Marker”: How will we know if the treatment is working? (e.g., “We will count how many times he wakes up at night for two weeks”).
  4. Monitor Side Effects: Is the child too sleepy to participate in therapy? Is their “good” muscle tone (the tone they use to sit up) getting too weak?
  5. Review Regularly: No treatment is forever. If a medication isn’t meeting the goal, work with your doctor to safely taper it off and try a different approach.
Symptom Initial Approach If Symptoms Persist
Worsening Stiffness Daily stretching, orthotics/braces [4]. Trial of oral baclofen or Botox injections [10][12].
Frequent Choking Seek an urgent feeding/swallow evaluation. Do not thicken liquids or change positioning without clinical direction [20]. VFSS swallow study and consultation for a G-tube [17][19].
Loss of Communication Seek urgent medical evaluation for regression, while continuing to use low-tech picture cards/signs [21]. Formal AAC evaluation for eye-gaze or switch-access tech [22].

Common questions in this guide

Does this syndrome have one standard treatment or a cure?
No single cure or universal treatment plan applies because the clinical description can be caused by changes in different genes. Care is usually multidisciplinary and tailored to the child’s movement, communication, swallowing, nutrition, comfort, and daily goals.
Which therapies can help a child with low tone and movement problems?
Physical therapy can support head control, positioning, motor skills, and prevention of tight muscles and joints. Occupational therapy helps with hand skills, seating, feeding tools, and daily activities, while speech-language therapy can support communication and early use of picture boards or electronic communication devices.
What medicines or injections may help spasticity or dystonia?
Depending on whether the child has spasticity, dystonia, or another movement pattern, clinicians may consider oral baclofen or trihexyphenidyl, botulinum toxin injections for a specific muscle group, or a baclofen pump for severe cases. These treatments require close monitoring, and baclofen must not be stopped suddenly because withdrawal can be dangerous.
When should a child with this syndrome have a swallowing evaluation?
Coughing, choking, wet-sounding breathing, repeated respiratory problems, or poor weight gain should prompt a clinical feeding and swallowing assessment. Because food or liquid can enter the lungs without coughing, a clinician may recommend a video fluoroscopic swallow study or FEES, and families should not thicken liquids or change positioning without guidance.
Can a G-tube prevent all aspiration or replace oral feeding?
A gastrostomy tube can provide nutrition when swallowing is unsafe or weight gain is inadequate, and it may reduce the stress of oral feeding. It does not prevent aspiration of saliva or reflux, and any oral pleasure feeds should follow an individualized swallowing plan.
How should we tell whether a new treatment is helping?
Choose a specific goal, such as fewer nighttime spasms, easier diaper changes, less pain, or sitting comfortably in a wheelchair for two hours. Track a simple measure and side effects, then review the plan regularly with the care team; medicines should be tapered safely rather than stopped on your own.
What can help if my child cannot speak reliably?
Augmentative and alternative communication, or AAC, can include picture boards, signs, switches, or eye-gaze devices, and it can be introduced early. A speech-language professional can help choose tools that let the child express needs, choices, and feelings even if spoken language is limited.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on X-linked intellectual disability-hypotonia-movement disorder syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which 'movement phenotype' does my child primarily show—spasticity, dystonia, or a mix of both—and how does that change our choice of medication?
  2. 2.If we start a medication like baclofen or trihexyphenidyl, what specific 'goal' are we tracking (e.g., easier diaper changes, better sleep, or less pain)?
  3. 3.Given my child's motor challenges, do you recommend a swallow study (VFSS) to check for 'silent aspiration' even if they aren't coughing during meals?
  4. 4.Does my child's specific genetic diagnosis suggest we should try a 'levodopa trial' for any parkinson-like symptoms?
  5. 5.What are the signs that my child might be ready for a gastrostomy (G-tube), and can it be used alongside 'pleasure feeding' by mouth under a safe plan?

References

References (22)
  1. 1

    Clinical and Biochemical Monitoring of Monocarboxylate Transporter 8 Deficiency (Allan-Herndon-Dudley Syndrome) across the Lifespan: Practical Considerations for Multidisciplinary Care.

    Dietrich JW, Jelesch E, Linder-Lucht M, et al.

    Hormone research in paediatrics 2026; 1-14 doi:10.1159/000551857.

    PMID: 41926547
  2. 2

    Patients with Allan-Herndon-Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment.

    Wilpert NM, Hewitt AL, Pons R, et al.

    Movement disorders : official journal of the Movement Disorder Society 2025; (40(5)):938-949 doi:10.1002/mds.30152.

    PMID: 40088079
  3. 3

    Redefining the Pediatric Phenotype of X-Linked Monocarboxylate Transporter 8 (MCT8) Deficiency: Implications for Diagnosis and Therapies.

    Matheus MG, Lehman RK, Bonilha L, Holden KR

    Journal of child neurology 2015; (30(12)):1664-8 doi:10.1177/0883073815578524.

    PMID: 25900139
  4. 4

    [A family with Allan-Herndon-Dudley syndrome due to SLC16A2 gene mutation].

    Tang YL, Peng J, Xiong J, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2018; (56(11)):829-834 doi:10.3760/cma.j.issn.0578-1310.2018.11.008.

    PMID: 30392207
  5. 5

    Clinical spectrum of KIAA2022/NEXMIF pathogenic variants in males and females: Report of three patients from Indian kindred with a review of published patients.

    Panda PK, Sharawat IK, Joshi K, et al.

    Brain & development 2020; (42(9)):646-654 doi:10.1016/j.braindev.2020.06.005.

    PMID: 32600841
  6. 6

    Social motivation a relative strength in DYRK1A syndrome on a background of significant speech and language impairments.

    Morison LD, Braden RO, Amor DJ, et al.

    European journal of human genetics : EJHG 2022; (30(7)):800-811 doi:10.1038/s41431-022-01079-w.

    PMID: 35437318
  7. 7

    Augmentative and alternative communication with children with severe/profound intellectual and multiple disabilities: speech language pathologists' clinical practices and reasoning.

    Rensfeld Flink A, Thunberg G, Nyman A, et al.

    Disability and rehabilitation. Assistive technology 2024; (19(3)):962-974 doi:10.1080/17483107.2022.2137252.

    PMID: 36327995
  8. 8

    Effects of Communication Partner Instruction on the Communication of Individuals using AAC: A Meta-Analysis.

    Kent-Walsh J, Murza KA, Malani MD, Binger C

    Augmentative and alternative communication (Baltimore, Md. : 1985) 2015; (31(4)):271-84 doi:10.3109/07434618.2015.1052153.

    PMID: 26059542
  9. 9

    Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency.

    Bruschi F, Vaia Y, Antonello CE, et al.

    Movement disorders : official journal of the Movement Disorder Society 2026; (41(2)):509-514 doi:10.1002/mds.70093.

    PMID: 41144879
  10. 10

    Effectiveness of Oral Baclofen in the Treatment of Spasticity in Children and Adolescents With Cerebral Palsy.

    Navarrete-Opazo AA, Gonzalez W, Nahuelhual P

    Archives of physical medicine and rehabilitation 2016; (97(4)):604-618 doi:10.1016/j.apmr.2015.08.417.

    PMID: 26321489
  11. 11

    Trihexyphenidyl for dystonia in cerebral palsy.

    Harvey AR, Baker LB, Reddihough DS, et al.

    The Cochrane database of systematic reviews 2018; (5()):CD012430 doi:10.1002/14651858.CD012430.pub2.

    PMID: 29763510
  12. 12

    Botulinum Toxin in Children with Cerebral Palsy: An Update.

    Hareb F, Bertoncelli CM, Rosello O, et al.

    Neuropediatrics 2020; (51(1)):1-5 doi:10.1055/s-0039-1694988.

    PMID: 31486052
  13. 13

    Adverse effects following botulinum toxin A injections in children with cerebral palsy.

    Sapienza M, Kapoor R, Alberghina F, et al.

    Journal of pediatric orthopedics. Part B 2023; (32(5)):435-451 doi:10.1097/BPB.0000000000001055.

    PMID: 36723611
  14. 14

    Best Practices for Intrathecal Baclofen Therapy: Patient Selection.

    Saulino M, Ivanhoe CB, McGuire JR, et al.

    Neuromodulation : journal of the International Neuromodulation Society 2016; (19(6)):607-15 doi:10.1111/ner.12447.

    PMID: 27434197
  15. 15

    Intrathecal Baclofen Therapy-Practical Approach: Clinical Benefits and Complication Management.

    Winter G, Beni-Adani L, Ben-Pazi H

    Journal of child neurology 2018; (33(11)):734-741 doi:10.1177/0883073818785074.

    PMID: 30009656
  16. 16

    Mapping dysphagia in pediatric dystonia.

    Keles MN, Serdaroglu E

    PloS one 2025; (20(6)):e0324140 doi:10.1371/journal.pone.0324140.

    PMID: 40531829
  17. 17

    Accuracy of clinical swallowing evaluation for diagnosis of dysphagia in children with laryngomalacia or glossoptosis.

    Gasparin M, Schweiger C, Manica D, et al.

    Pediatric pulmonology 2017; (52(1)):41-47 doi:10.1002/ppul.23484.

    PMID: 27228428
  18. 18

    Clinical outcomes before and after videofluoroscopic swallow study in children 24 months of age or younger.

    Barth FL, Levy DS, Gasparin M, et al.

    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2024; (50(1)):e20230290 doi:10.36416/1806-3756/e20230290.

    PMID: 38536983
  19. 19

    Diagnosis and Management of Pediatric Dysphagia: A Review.

    Lawlor CM, Choi S

    JAMA otolaryngology-- head & neck surgery 2020; (146(2)):183-191 doi:10.1001/jamaoto.2019.3622.

    PMID: 31774493
  20. 20

    Using the BaByVFSS Impairment Profile to Characterize the Impact of Thin and Mildly Thick Liquid Consistencies on Validated Physiological Components of Swallowing in Bottle-Fed Children.

    Lefton-Greif MA, Carson KA, Pinto JM, Martin-Harris B

    American journal of speech-language pathology 2025; (34(6)):3454-3465 doi:10.1044/2025_AJSLP-25-00203.

    PMID: 41161678
  21. 21

    A delayed intervention start randomized controlled trial of high- and low-tech communication training approaches for school-age autistic children with co-occurring intellectual disability.

    Gilroy SP, McCleery JP, Leader G

    Journal of applied behavior analysis 2023; (56(3)):593-606 doi:10.1002/jaba.989.

    PMID: 37092868
  22. 22

    Demands Associated With an Augmentative and Alternative Communication System in Relation to Alternative Forms of Access for Individuals With Motor Impairments.

    Sowers DJ, Wilkinson KM

    American journal of speech-language pathology 2023; (32(1)):37-54 doi:10.1044/2022_AJSLP-22-00006.

    PMID: 36599109

This page describes supportive care for children with X-linked intellectual disability-hypotonia-movement disorder syndrome for informational purposes only and does not constitute medical advice. Your child’s clinicians should individualize medicines, therapy goals, feeding plans, communication tools, and G-tube decisions.